Ana is a molecular biologist enthusiastic about innovation and communication. In her role as a science writer she wishes to bring the advances in medical science and technology closer to the public, particularly to those most in need of them. Ana holds a PhD in Biomedical Sciences from the University of Lisbon, Portugal, during which she focused her research on molecular biology, epigenetics and infectious diseases.
Arena Pharmaceuticals announced full long-term results of its OASIS extension study, confirming that once-daily oral etrasimod leads to sustained clinical responses and favorable safety for up to 46 weeks ... Read more
An experimental cell therapy for Crohn’s disease that involves taking the patient’s white blood cells, restoring their proper functioning in the lab, and giving them back to the patient, ... Read more